The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

Molecular Pharmacology

Volumn 69, Issue 2, 2006, Pages 471-478

  Gary Bobo, Magali ^a   Elachouri, Ghizlane ^a   Scatton, Bernard ^a   Le Fur, Gérard ^a   Oury Donat, Florence ^a   Bensaid, Mohammed ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CELL MARKER; FAT DROPLET; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RIMONABANT;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BODY FAT; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; STIMULATION;

ADIPOCYTES; ADIPONECTIN; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); LIPID METABOLISM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER;

EID: 31044456243     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.015040     Document Type: Article

References (44)

1. Ailhaud G (1997) Molecular mechanisms of adipocyte differentiation. J Endocrinol 155:201-202.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83.
3. Arnone M, Maruani J, Chaperon F, Thiébot M-H, Poncelet M, Soubrié P, and Le Fur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716 an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132:104-106.
4. 1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63:908-914.
5. Borst SE (2004) The role of TNF-alpha in insulin resistance. Endocrine 23:177-182.
6. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, et al. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. J Biol Chem 272:22330-22339.
7. Carpino PA (2000) Patent focus on new anti-obesity agents: September 1999-February 2000. Exp Opin Ther Patents 10:819-831.
8. 1) receptors in the establishment of place conditioning in rats. Psychopharmacology 135:324-332.
9. Colombo G, Agabio R, Diaz G, Lobina C, Reali R, and Gessa GL (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716 Life Sci 63:113-117.
10. Deslex S, Negrel R, and Ailhaud G (1987) Development of a chemically defined serum-free medium for differentiation of rat adipose precursor cells. Exp Cell Res 168:15-30.
11. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkal S, Jaral Z, Fezza F, Milura GI, Palmiter RD, Sugiura T, et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature (Lond) 410:822-825.
12. Dugail I, Quignard-Boulange A, Brigant L, Etienne J, Noe L, and Lavau M (1988) Increased lipoprotein lipase content in the adipose tissue of suckling and weaning obese Zucker rats. Biochem J 249:45-49.
13. Dugail I, Quignard-Boulange A, Le Liepvre X, Ardouin B, and Lavau M (1992) Gene expression of lipid storage-related enzymes in adipose tissue of the genetically obese Zucker rat. Co-ordinated increase in transcriptional activity and potentiation by hyperinsulinaemia. Biochem J 281:607-611.
14. Engelman JA, Lisanti MP, and Scherer PE (1998) Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 273:32111-32120.
15. Fain JN, Madan AK, Hiler ML, Cheema P, and Bahouth SW (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273-2282.
16. Fajas L, Debril M-B, and Auwerx J (2001) Peroxisome proliferators- activated receptor-γ: from adipogenesis to carcinogensis. J Mol Endocinol 24:1-9.
17. Fortuno A, Rodriguez A, Gomez-Ambrosi J, Fruhbeck G, and Diez J (2003) Adipose tissue as an endocrine organ: role of leptin and adiponectin in pathogenesis of cardiovascular diseases. J Physiol Biochem 59:51-60.
18. Fried SK and Russell C (1998) Diverse roles of adipose tissue in the regulation of systematic metabolism and energy balance, in Handbook of Obesity (Bray GA, Bouchard C, and James W eds) p. 397-413 Marcel Dekker, New York.
19. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, and Lodish HF (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010.
20. 1 cannabinoid receptor. Mol Pharmacol 62:1385-1392.
21. Green H and Kehinde O (1973) Sublines of mouse 3T3 cells that accumulate lipid. Cell 1:113-116.
22. Grundy SM (2004) Obesity, metabolic syndrome and cardiovascular disease. J Clin Endocrinol Metab 89:2595-2600.
23. Guerre-Millo M (2002) Adipose tissue hormones. J Endocrinol Investig 25:855-861.
24. Guillot E, Le Bail JC, Le Claire S, Lechevalier P, Jagerschmidt A, Validire P, Baumert H, and Galzin AM (2003) Evidence for CB1 cannabinoid receptor (CB1R) expression in the human adipocyte. Effect of the CB1R antagonist SR141716 (rimonabant) on pre-adipocyte differentiation. Abstract presented at the North American Association for the Study of Obesity (NAASO) 2003 Annual Meeting. Obesity Research; 2003 Oct 11-15; Ft. Lauderdale, FL.
25. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, and Martin JR (2001) The biology of white adipocyte proliferation. Obes Rev 2:239-254.
26. Hirsch J, Fried SK, Edens NK, and Leibel RL (1989) The fat cell. Med Clin North Am 73:83-96.
27. Hu E, Liang P, and Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703.
28. Kuri-Harcuch W and Green H (1977) Increasing activity of enzymes on pathway of triacylglycerol synthesis during adipose conversion of 3T3 cells. J Biol Chem 252:2158-2160.
29. Lyon CJ, Law RE, and Hsueh WA (2003) Minireview: adiposity, inflammation and atherogenesis. Endocrinology 144:2195-2200.
30. Matsuzawa Y, Funahashi T, Kihara S, and Shimomura I (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24:29-33.
31. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, and Rimm EB (2004) Plasma adiponectin levels and risk of myocardial infarction in men. J Am Med Assoc 291:1730-1737.
32. Poirier B, Bidouard JP, Cadrouvele C, Marniquet X, Staels B, O'Connor SE, Janiak P, and Herbert JM (2005) The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes Obes Metab 7:65-72.
33. Prins JB and O'Rahilly S (1997) Regulation of adipose cell number in man. Clin Sci 92:3-11.
34. Rajala MW and Scherer PE (2003) Minireview: the adipocyte - At the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 144:3765-3773.
35. Ravinet-Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP, and Soubrié P (2002) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol 284:R345-R353.
36. Reilly MP and Rader DJ (2003) The metabolic syndrome more than the sum of its parts? Circulation 108:1546-1551.
37. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
38. Rolland V, Dugail I, Le Liepvre X, and Lavau M (1995) Evidence of increased gylceraldehyde-3-phosphate dehydrogenase and fatty acid synthetase promoter activities in transiently transfected adipocytes from genetically obese rats. J Biol Chem 270:1102-1106.
39. Ruan H and Lodish HF (2003) Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α. Cytokine Growth Factor Rev 14:447-455.
40. Spiegelman BM and Flier JS (2001) Obesity and the regulation of energy balance. Cell 104:531-543.
41. Trayhurn P and Beattie JH (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nut Soc 60:329-339.
42. Trayhurn P and Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347-355.
43. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, and Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935.
44. Wisse BE (2004) The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15:2792-2800.